Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 10.95 is 48% above its 3-year average of 7.41, near the high end of its 3-year range (0.00–11.97).
As of the fiscal period ended Tuesday, June 30, 2026. 6.29% above its 12-month average of 10.30.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 10.95.
CURRENT RATIO
10.95
CURRENT RATIO AVG TTM
10.30
CURRENT RATIO AVG 3Y
10.27
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+6.29%
CURRENT VS 3Y AVG
+6.59%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.52
median of 731 covered companies
CURRENT VS SECTOR MEDIAN
+211.06%
vs the sector median at left
Market Cap
$5.97B
Current Ratio
31.18
TTM Avg
15.58
3Y Avg
12.00
5Y Avg
10.69
Market Cap
$5.86B
Current Ratio
4.35
TTM Avg
3.47
3Y Avg
3.74
5Y Avg
5.38
Market Cap
$5.77B
Current Ratio
3.90
TTM Avg
3.54
3Y Avg
4.15
5Y Avg
5.24
Market Cap
$5.55B
Current Ratio
1.81
TTM Avg
1.62
3Y Avg
1.66
5Y Avg
1.66
Market Cap
$6.44B
Current Ratio
3.45
TTM Avg
3.83
3Y Avg
5.53
5Y Avg
6.55
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GRAIL Inc. (GRAL) | $5.96B | 10.95 | 10.30 | 10.27 | N/A |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $5.97B | 31.18 | 15.58 | 12.00 | 10.69 |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.86B | 4.35 | 3.47 | 3.74 | 5.38 |
| Kiniksa Pharmaceuticals International, plc (KNSA)vs › | $5.77B | 3.90 | 3.54 | 4.15 | 5.24 |
| CG Oncology Inc. (CGON)vs › | $5.71B | 22.22 | 29.96 | 20.77 | 18.57 |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.55B | 1.81 | 1.62 | 1.66 | 1.66 |
| RadNet, Inc. (RDNT)vs › | $5.51B | 1.48 | 1.94 | 1.50 | 1.26 |
| Rhythm Pharmaceuticals, Inc. (RYTM)vs › | $6.44B | 3.45 | 3.83 | 5.53 | 6.55 |
| Lantheus Holdings, Inc. (LNTH)vs › | $6.51B | 3.06 | 4.11 | 4.19 | 3.61 |
| Amneal Pharmaceuticals, Inc. (AMRX)vs › | $6.53B | 2.20 | 1.79 | 1.77 | 1.94 |
Current Ratio
10.95
Quick Ratio
10.74
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 10.95 |
| 2026-03-31 | 11.74 |
| 2025-12-31 | 11.97 |
| 2025-09-30 | 7.61 |
| 2025-06-30 | 9.23 |
| 2025-03-31 | 9.71 |
| 2024-12-31 | 10.66 |
| 2024-09-30 | 9.65 |
| 2024-06-30 | 11.55 |
| 2024-03-31 | 9.65 |
| 2023-12-31 | 0.95 |
| 2023-09-30 | 0.00 |
| 2023-06-30 | 0.00 |
| 2023-04-02 | 0.00 |
